Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2008 | 12-2007 | 12-2006 | |
Sales | 0 | 344 | 0 |
Gross Profit | N/A | 344 | N/A |
Operating Income | N/A | 344 | N/A |
Pre-tax Income | 0 | 344 | 0 |
Net Income Continuous | -45,552 | -31,689 | N/A |
Net Income | $-45,552 | $-31,689 | $N/A |
EPS Basic Total Ops | -81.70 | -60.10 | N/A |
EPS Basic Continuous Ops | -73.48 | -51.30 | N/A |
EPS Diluted Total Ops | -81.70 | -60.10 | N/A |
EPS Diluted Continuous Ops | -73.48 | -51.30 | N/A |
EBITDA(a) | $N/A | $344 | $N/A |